| Primary |
| Dry Eye |
61.5% |
| Drug Use For Unknown Indication |
30.8% |
| Product Used For Unknown Indication |
7.7% |
|
| Vision Blurred |
27.3% |
| Photophobia |
18.2% |
| Cataract |
9.1% |
| Eye Irritation |
9.1% |
| Hypersensitivity |
9.1% |
| Pharmaceutical Product Complaint |
9.1% |
| Swollen Tongue |
9.1% |
| Visual Acuity Reduced |
9.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
53.1% |
| Dry Eye |
20.4% |
| Postoperative Care |
16.3% |
| Blood Cholesterol Increased |
4.1% |
| Prophylaxis |
4.1% |
| Dementia |
2.0% |
|
| Thrombocytopenia |
41.7% |
| Vision Blurred |
16.7% |
| Blindness |
8.3% |
| Corneal Opacity |
8.3% |
| Drug Ineffective |
8.3% |
| Eye Irritation |
8.3% |
| Photophobia |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.1% |
| Dry Eye |
13.6% |
| Drug Use For Unknown Indication |
11.8% |
| Vitamin Supplementation |
8.6% |
| Hypertension |
7.3% |
| Rheumatoid Arthritis |
6.4% |
| Medical Diet |
3.9% |
| Crohn's Disease |
3.8% |
| Ulcerative Keratitis |
3.6% |
| Hepatitis C |
2.7% |
| Hiv Infection |
2.7% |
| Prophylaxis |
2.5% |
| Sinusitis |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Pain |
2.0% |
| Retinal Detachment |
1.8% |
| Atrial Fibrillation |
1.6% |
| Mediastinitis |
1.6% |
| Diabetes Mellitus |
1.4% |
| Diarrhoea |
1.4% |
|
| Toxic Epidermal Necrolysis |
8.2% |
| Ocular Hyperaemia |
6.8% |
| Resorption Bone Increased |
6.8% |
| Crohn's Disease |
5.5% |
| Eye Irritation |
5.5% |
| Impaired Healing |
5.5% |
| Pernicious Anaemia |
5.5% |
| Pyrexia |
5.5% |
| Renal Failure Acute |
5.5% |
| Renal Tubular Necrosis |
5.5% |
| Vision Blurred |
5.5% |
| Cytolytic Hepatitis |
4.1% |
| Foreign Body Sensation In Eyes |
4.1% |
| Hypertension |
4.1% |
| Lung Disorder |
4.1% |
| Pancytopenia |
4.1% |
| Psoriasis |
4.1% |
| Vomiting |
4.1% |
| Death |
2.7% |
| Depressed Level Of Consciousness |
2.7% |
|
